Betabloqueadores en pacientes posinfarto de miocardio

Britto FW. Recomendaciones para el manejo del infarto de miocardio con elevación del segmento ST luego de la reperfusion. Arch Peru Cardiol Cir Cardiovasc. 2025;6(7): 154 – 161, DOI: 10.47487/apcyccv.v6i3.508.

Ibañez B, Latini R, Rosello X, Dominguez-Rodriguez A, Renandez-Vazquez F, Pelizzoni V. et al. Beta blockers after Myocardial Infarction without Reduced Ejection Fraction. N Engl J Med 2025; 393: 1889 – 900. DOI: 10.1056/NEJMoa2504735

Munkhaucen J, Kristensen A, Halversen S, Holmager T, Olsen M, Bakken A, et al. Beta-blockers after Myocardial Infarction in Patients without Heart Failure. N Engl J Med 2025; 393: 1901 – 11. DOI: 10.1056/NEJM oa2505986.

Rosello X, Bossano Prescott E, Kristensen A, Latini R, Fuster V, Wong Fagerland M, et al. Beta blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomized controlled trials. Lancet 2025; 406: 1128-37. DOI: 10.1016/50140-6736(25)01592-2

Kristensen A, Rosello X, Atar D, Yndigegn T, Kimura T, Latini R, et al. Beta blockers after myocardial infarction with Normal Ejection Fraction. N Engl J Med. 2025 Nov 9. doi: 10.1056/NEJMoa2512686. Epub ahead of print.

Kaul S. Reevaluating Beta-Blocker Recommendations PostMyocardial Infarction. Perspective on the 2025 Guideline Update. JACC 2025;85(2):2096 – 99. DOI: 10.1016/j.jacc.2025.03.539.

Cataldo Miranda P, Gasevic D, Trin C, Stub D, Zoungas S, Kaye DM, et al. Beta-Blocker Therapy After Myocardial Infarction. JACC Adv. 2025 Mar;4(3):101582. doi: 10.1016/j.jacadv.2024.101582.

Yndigegn T, Lindahl B, Mars K, Alfredson J, Benatar J, Brandin L, et al. Beta blockers after Myocardial Infarction and preserved Ejection Fraction. N Engl J Med 2024; 390: 1372 – 81. DOI: 10.1056/NEJMoa2401479.

Watanabe H, Ozasa N, MorimotoT, Shiomi H, Bingyuan B, et al. Long term use of carvedilol in patients with ST-segment elevation myocardial infarction trated with primary percutaneous coronary intervention. PLos ONE 13 (8): e199347. DOI: 10.1371/journal.pone.0199347.

Rosello X, Dominguez-Rodriguez A, Latini R, Sanchez P, Raposeras-Reulan S, Anguita M, et al. Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial. Eur Heart J. 2026 Feb 11;47(6):701-715. doi: 10.1093/eurheartj/ehaf673

McGowan J, Cleland J. Reliability of reporting left ventricuar systolic function by echocardiography: A systematic review of 3 methods. Am Heart J 2003; 146: 388-97.

Rosello X, Sánchez P, Owen R, Raposeiras-Roubin S, Poletti F, Barrabes J, et al. Effect of beta blocker witholding or withdrawal after myoardial infarction without reduced ejection fraction on ischemic events: a post hoc análisis from the REBOOT trial. Eurointervenion 2025;21:e1434-e1444